MM&M is calling for nominations for the 2018 class of Top 40 Healthcare Transformers and is seeking industry input for the Top 10 Innovation Catalysts.
Five things for pharma marketers to know: Thursday, January 4, 2018
Walgreens ends merger with Rite Aid; Biogen hires former Novartis exec as SVP of corporate affairs; FDA takes new measures to drive drug pricing competition
Five things for pharma marketers to know: Thursday, June 22, 2017
The FDA plans public meeting to encourage generic competition; Mylan reportedly offered rebates to six Medicaid programs; Republicans to present draft bill for Obamacare replacement
Five things for pharma marketers to know: Tuesday, May 23, 2017
Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent pharma history.
Study: Medical-marijuana laws lower prescription drug usage
April 25, 2017
1:45 pm
The research found a reduction in utilization of medications used to treat depression, nausea, and psychosis when looking at data for Medicaid beneficiaries.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix